Haleon (HLNCF) Shares Outstanding (Weighted Average) (2021 - 2025)
Haleon (HLNCF) recorded quarterly Shares Outstanding (Weighted Average) of $119.7 million in Q4 2025, up 2.5% on a QoQ basis from $116.8 million in Q4 2024, and up 2.5% year-over-year from $116.8 million in Q4 2024.
Haleon (HLNCF) Shares Outstanding (Weighted Average) (2021 - 2025) Analysis & Trends
Haleon has disclosed Shares Outstanding (Weighted Average) across 5 years of filings, most recently posting $119.7 million for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 2.5% year-over-year to $119.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $119.7 million (up 2.5% YoY) and the FY2025 annual result came in at $118.7 million, up 2.01% from the prior year.
- Shares Outstanding (Weighted Average) rose to $119.7 million in Q4 2025, from $116.8 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $115.1 billion in Q2 2023 and troughed at $116.8 million in Q4 2024.
- A 5-year average of $17.3 billion and a median of $8.4 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) jumped 9041.91% — and 2024, when it plunged 98.98%.
- Tracing HLNCF's Shares Outstanding (Weighted Average) over 5 years: stood at $12.4 billion in 2021, then retreated by 12.99% to $10.8 billion in 2022, then rose by 5.79% to $11.5 billion in 2023, then tumbled by 98.98% to $116.8 million in 2024, then advanced by 2.5% to $119.7 million in 2025.
- Business Quant data shows HLNCF's Shares Outstanding (Weighted Average) at $119.7 million in Q4 2025, $116.8 million in Q4 2024, and $10.0 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Haleon | - | - | - | 119.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 119.71 Mn |
| Dec 31, 2024 | 116.80 Mn |
| Jun 30, 2024 | 9.97 Bn |
| Dec 31, 2023 | 11.46 Bn |
| Jun 30, 2023 | 115.13 Bn |
| May 3, 2023 | 5.14 Bn |
| Dec 31, 2022 | 10.83 Bn |
| Sep 20, 2022 | 6.90 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Dec 31, 2021 | 12.45 Bn |